Clinical Trial Update: Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab with enfortumab vedotin, with pembrolizumab given before and after radical nephroureterectomy for high-risk upper tract u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• Enfortumab Vedotin (Padcev) (enfortumab vedotin)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Renal Pelvis and Ureter Urothelial Carcinoma | Phase 2 | Status: RECRUITING